SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
79.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (3)
○ MHRA GMP
Quick Facts: SK pharmteco
- Signal Score
- 79.5/100 (as of 2026-09-07)
- Quality Compliance
- 100.0/100
- Headquarters
- Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
- Website
- https://sk-pharmteco.com
- Modalities
- Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
100.0
FDA InspectionsNo US records on file
EMA GMP Certificates3 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesViral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
63.0
Capacity status: Available
StatusAvailable
SK pharmteco EMA GMP Compliance 3 certificates
2025-11
2025-11
2022-04
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 2026_HPF_FR_076_IV | YposKesi | France | 2025-11-28 | COMPLIANT |
| 2026_HPF_FR_075_IV | YposKesi | France | 2025-11-28 | COMPLIANT |
| 2022_HPF_FR_143_1_P_2025 | YposKesi | France | 2022-04-08 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 07, 2026
Frequently Asked Questions About SK pharmteco
Does SK pharmteco hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 EMA GMP certificates for SK pharmteco.
What is SK pharmteco's CDMO Signal Score?
SK pharmteco has a Signal Score of 80/100, based on quality, operations, financial stability, and capacity data.
Evaluating SK pharmteco for a manufacturing program?
Use the free AI matchmaker to compare SK pharmteco against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Lonza Biologics
Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH
Signal Score: 73.0
AAV, Lentiviral, Cell Therapy, mRNA, Monoclonal Antibody, Recombinant Protein
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 81.0
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid
OmniaBio
Hamilton, ON
Signal Score: 79.5
AAV, Lentiviral, CAR-T, Cell Therapy
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 78.6
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein